Par Pharmaceutical Companies, Inc. - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Electronic

Par Pharmaceutical Companies, Inc.
Wright Investors' Service, May 2009, Pages: 44


	Description



		Table of Contents



		Companies Mentioned



		Enquire before Buying



		Send to a Friend

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Par Pharmaceutical Companies, Inc.. There is a textual review of the financial results of Par Pharmaceutical Companies, Inc. versus K-V Pharmaceutical Company, Medicis Pharmaceutical Corporation and Schwarz Pharma AG. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Par Pharmaceutical Companies, Inc. are the Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and Key Data Items (Ticker, Major Industry, Sub-Industry, Fiscal Year End Month, Employees, Share Type, Market Capitalization, Total Shares Outstanding and Number of Closely Held Shares.) Additional research for Par Pharmaceutical Companies, Inc.includes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices.

Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Haw Par Corporation Limited

Par Technology Corporation

Par Pharmaceutical Companies, Inc. - Financial and Strategic Analysis Review

Par Pharmaceutical Companies, Inc. - SWOT Analysis - SWOT Analysis

Hisamitsu Pharmaceutical Co., Inc.

China Aoxing Pharmaceutical Company, Inc.

DOV Pharmaceutical, Inc.

Dragon Pharmaceutical Inc

Biomarin Pharmaceutical Inc

Genex Pharmaceutical, Inc.

West Pharmaceutical Services, Inc.

Shanghai Pharmaceutical Company Limited

Top of page